ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Denali Therapeutics Inc

Denali Therapeutics Inc (DNLI)

23.53
2.07
(9.65%)
Closed July 23 4:00PM
23.57
0.04
(0.17%)
After Hours: 7:50PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
23.57
Bid
23.15
Ask
23.75
Volume
3,222,048
21.25 Day's Range 23.70
14.56 52 Week Range 29.22
Market Cap
Previous Close
21.46
Open
21.62
Last Trade Time
Financial Volume
$ 71,694,795
VWAP
22.2513
Average Volume (3m)
1,175,231
Shares Outstanding
142,609,036
Dividend Yield
-
PE Ratio
-23.20
Earnings Per Share (EPS)
-1.02
Revenue
330.53M
Net Profit
-145.22M

About Denali Therapeutics Inc

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $21.46. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 29.22.

Denali Therapeutics currently has 142,609,036 shares outstanding. The market capitalization of Denali Therapeutics is $3.06 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -23.20.

DNLI Latest News

Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological products for rare diseasesDNL126 was selected...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.622.7015250544722.9524.121.2389848022.90759021CS
40.944.1537781705722.6324.120.43114189822.47165321CS
127.9350.703324808215.6424.115.21117523120.73174108CS
266.2836.321573163717.2924.114.56119410619.56940734CS
52-5.55-19.059065934129.1229.2214.56102985820.1444945CS
156-41.91-64.004276114865.4866.7914.5676935227.34195143CS
2602.5712.23809523812193.9412.3968305532.25220464CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.15M
CMAXCareMax Inc
$ 5.19
(228.48%)
102.64M
NUKKNukkleus Inc
$ 0.499
(55.94%)
26.2M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.88M
ONDSOndas Holdings Inc
$ 1.1297
(34.06%)
2.19M
CGBSCrown LNG Holdings Ltd
$ 0.9902
(-29.77%)
3.29M
LGCBLinkage Global Inc
$ 3.7833
(-27.45%)
166.7k
SPECSpectaire Holdings Inc
$ 0.395
(-24.76%)
1.78M
GSUNGolden Sun Health Technology Group Ltd
$ 5.07
(-24.55%)
155.37k
SLNASelina Hospitality PLC
$ 0.0364
(-23.04%)
75.77M
NVDANVIDIA Corporation
$ 123.45
(4.68%)
221.22M
SQQQProShares UltraPro Short QQQ
$ 8.08
(-4.49%)
176.65M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
151.42M
SERVServe Robotics Inc
$ 8.7192
(15.49%)
148.59M
NCPLNetcapital Inc
$ 0.1105
(6.25%)
121.97M

DNLI Discussion

View Posts
conix conix 2 years ago
DNLI on Seeking Alpha

https://seekingalpha.com/article/4570210-denali-need-patient-data-to-justify-that-high-valuation
πŸ‘οΈ0
seward seward 2 years ago
Up big, why?
πŸ‘οΈ0
seward seward 3 years ago
Up 5 pts AH news or random bid ?
πŸ‘οΈ0
seward seward 3 years ago
Add 55.55

Been holding for 100+, flipping small shares
πŸ‘οΈ0
seward seward 3 years ago
More flipping.

Filled for one share at 57 this morning. If it hits 62 I can buy coffee.

hans
πŸ‘οΈ0
seward seward 3 years ago
Good earnings, flipped some in low 60s
πŸ‘οΈ0
seward seward 4 years ago
Adding a little on pullbacks, still looking to hold till it breaks 100 and then sone.
πŸ‘οΈ0
seward seward 4 years ago
Best stock I’ve ever seen. Next stop 100 ?
πŸ‘οΈ0
seward seward 4 years ago
Up up up. I suppose I should sell it some day. Maybe over 100 ?
πŸ‘οΈ0
seward seward 4 years ago
14 may not be in the cards. I may wait for 100.

hans
πŸ‘οΈ0
seward seward 5 years ago
Up nice today for no apparent reason.

hans
πŸ‘οΈ0
Glider549 Glider549 5 years ago
Interesting .
Stockconsultant daut kom sent me here.
Any debt? Toxic debt?
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Back to $14 then do it again!
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Looking into if they have a stake in private company Blaze Bioscience and their scorpion venom..GLTA
πŸ‘οΈ0
seward seward 6 years ago
In at 14.30, already near 17. Lucky.
πŸ‘οΈ0
seward seward 6 years ago
"Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease"

I bought some today

hans
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock